28412693|t|Feeding Angptl4-/- mice trans fat promotes foam cell formation in mesenteric lymph nodes without leading to ascites
28412693|a|ANGPTL4 regulates plasma triglyceride levels by inhibiting lipoprotein lipase. Inactivation of ANGPTL4 decreases plasma triglycerides and reduces risk of coronary artery disease. Unfortunately, targeting ANGPTL4 for the therapeutic management of dyslipidemia and atherosclerosis is hampered by the observation that mice and monkeys in which ANGPTL4 is inactivated exhibit lipid accumulation in mesenteric lymph nodes. In mice these pathological events exclusively unfold upon feeding a high saturated fatty acid diet and are followed by an ultimately lethal pro-inflammatory response and chylous ascites. Here we show that Angptl4-/- mice fed a diet rich in trans fatty acids develop numerous lipid -filled giant cells in their mesenteric lymph nodes, yet do not have elevated serum amyloid and haptoglobin, do not exhibit ascites, and survive, unlike Angptl4-/- mice fed a saturated fatty acid -rich diet. In RAW264.7 macrophages the saturated fatty acid palmitate markedly increases markers of inflammation and the unfolded protein response, whereas the trans-unsaturated elaidate and the cis-unsaturated oleate have the opposite effect. In conclusion, trans and saturated fatty acids have very distinct biological effects. Furthermore, lipid accumulation in mesenteric lymph nodes is uncoupled from activation of an acute-phase response and chylous ascites, suggesting that ANGPTL4 should not be fully dismissed as target for dyslipidemia.
28412693	8	18	Angptl4-/-	T017	UMLS:C1423931
28412693	19	23	mice	T204	UMLS:C0206745
28412693	24	33	trans fat	T103	UMLS:C1257879
28412693	43	52	foam cell	T017	UMLS:C0016390
28412693	66	88	mesenteric lymph nodes	T017	UMLS:C0229792
28412693	108	115	ascites	T033	UMLS:C0003962
28412693	116	123	ANGPTL4	T103	UMLS:C1438918
28412693	134	140	plasma	T031	UMLS:C0032105
28412693	141	153	triglyceride	T103	UMLS:C0041004
28412693	175	193	lipoprotein lipase	T103	UMLS:C0023816
28412693	195	207	Inactivation	T038	UMLS:C0598496
28412693	211	218	ANGPTL4	T103	UMLS:C1438918
28412693	229	235	plasma	T031	UMLS:C0032105
28412693	236	249	triglycerides	T103	UMLS:C0041004
28412693	270	293	coronary artery disease	T038	UMLS:C0010068
28412693	320	327	ANGPTL4	T103	UMLS:C1438918
28412693	348	358	management	T058	UMLS:C0086388
28412693	362	374	dyslipidemia	T038	UMLS:C0242339
28412693	379	394	atherosclerosis	T038	UMLS:C0004153
28412693	431	435	mice	T204	UMLS:C0025929
28412693	440	447	monkeys	T204	UMLS:C0026447
28412693	457	464	ANGPTL4	T103	UMLS:C1438918
28412693	488	506	lipid accumulation	T033	UMLS:C0333574
28412693	510	532	mesenteric lymph nodes	T017	UMLS:C0229792
28412693	537	541	mice	T204	UMLS:C0025929
28412693	602	627	high saturated fatty acid	T168	UMLS:C0597423
28412693	628	632	diet	T168	UMLS:C0012155
28412693	667	673	lethal	T033	UMLS:C3151529
28412693	674	699	pro-inflammatory response	T038	UMLS:C1155266
28412693	704	719	chylous ascites	T038	UMLS:C0008732
28412693	739	749	Angptl4-/-	T017	UMLS:C1423931
28412693	750	754	mice	T204	UMLS:C0206745
28412693	761	765	diet	T168	UMLS:C0012155
28412693	774	791	trans fatty acids	T103	UMLS:C1257879
28412693	809	814	lipid	T103	UMLS:C0023779
28412693	823	834	giant cells	T017	UMLS:C0016390
28412693	844	866	mesenteric lymph nodes	T017	UMLS:C0229792
28412693	893	898	serum	T031	UMLS:C0229671
28412693	899	906	amyloid	T103	UMLS:C0002716
28412693	911	922	haptoglobin	T103	UMLS:C0018595
28412693	939	946	ascites	T033	UMLS:C0003962
28412693	968	978	Angptl4-/-	T017	UMLS:C1423931
28412693	979	983	mice	T204	UMLS:C0206745
28412693	990	1010	saturated fatty acid	T168	UMLS:C0597423
28412693	1017	1021	diet	T168	UMLS:C0012155
28412693	1026	1046	RAW264.7 macrophages	T017	UMLS:C0024432
28412693	1051	1081	saturated fatty acid palmitate	T103	UMLS:C3503116
28412693	1101	1108	markers	T201	UMLS:C0005516
28412693	1112	1124	inflammation	T038	UMLS:C0021368
28412693	1133	1158	unfolded protein response	T038	UMLS:C1155342
28412693	1172	1198	trans-unsaturated elaidate	T103	UMLS:C3886672
28412693	1207	1229	cis-unsaturated oleate	T103	UMLS:C0220884
28412693	1271	1276	trans	T103	UMLS:C1257879
28412693	1281	1302	saturated fatty acids	T168	UMLS:C0597423
28412693	1355	1373	lipid accumulation	T033	UMLS:C0333574
28412693	1377	1399	mesenteric lymph nodes	T017	UMLS:C0229792
28412693	1435	1455	acute-phase response	T038	UMLS:C0001349
28412693	1460	1475	chylous ascites	T038	UMLS:C0008732
28412693	1493	1500	ANGPTL4	T103	UMLS:C1438918
28412693	1545	1557	dyslipidemia	T038	UMLS:C0242339